SalvaRx Group plc reported unaudited consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported operating loss of £1,439,000 compared to £11,000 a year ago. Loss before tax was £1,464,000 compared to £11,000 a year ago. Net loss and comprehensive loss attributable to owners of the company was £1,319,000 or 0.05 pence per basic and diluted share compared to £11,000 or 0.00 pence per basic and diluted share a year ago. Net cash outflow from operating activities was £640,000 compared to £510,000 a year ago.